BioGaia AB (publ)
BIOG-B
주식 순위
#7843
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
주가
$13.86
마지막 동기화: 2026-10-16
시가총액
$1.37B
변동 (1일)
0.65%
변동 (1년)
23.21%
국가
SE
거래 BioGaia AB (publ) (BIOG-B)
카테고리
Healthcare
의 시가총액 BioGaia AB (publ)(BIOG-B)
시가총액: $1.37B
October 2026 기준으로 BioGaia AB (publ)의 시가총액은 $1.37B입니다. 이는 당사 데이터에 따르면 BioGaia AB (publ)이 세계에서 7843rd번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2015부터 2026까지 BioGaia AB (publ)의 시가총액 기록
